Advertisement
Advertisement
European Union
Get more with myNEWS
A personalised news feed of stories that matter to you
Learn more
Austrian Chancellor Sebastian Kurz. Photo: APA / AFP

Coronavirus: six EU leaders warn of ‘huge disparities’ in vaccine distribution

  • The countries called on EU officials ‘to hold a discussion on this important matter among leaders as soon as possible’
  • Austrian Chancellor Sebastian Kurz said vaccine doses were not being handed out proportionally among EU member states

The leaders of six European Union countries called on Saturday for high-level EU talks on the equitable distribution of coronavirus vaccine doses, saying the current system would create “huge disparities” among member states by the summer.

The leaders of Austria, Bulgaria, the Czech Republic, Latvia and Slovenia said in a letter to EU officials that the current system “would continue creating and exacerbating huge disparities among member states by this summer, whereby some would be able to reach herd immunity in a few weeks, while others would lag far behind.”

Croatia also joined the initiative later on Saturday.

The letter, addressed to EU Council President Charles Michel and Commission President Ursula von der Leyen, called on EU officials “to hold a discussion on this important matter among leaders as soon as possible.”

According to the bloc's vaccine strategy, all EU countries get access to approved shots at the same time, with distribution of available doses linked to population size.

But Austrian Chancellor Sebastian Kurz said on Friday that doses were not being handed out proportionally among EU member states, as additional supply contracts were being agreed upon as the result of non-transparent negotiations in an EU steering group.

According to Kurz, Denmark and the Netherlands have access to significantly more vaccine doses per capita than countries like Bulgaria or Croatia.

The European Commission negotiated six vaccine supply contracts with pharmaceutical companies on behalf of the 27 member states, which could opt in or out of each pre-order and choose how many doses to buy.

The EU executive branch said on Saturday that the reason for differences in dose allocations was down to member states' own decision not to take on all of their population-weighted share.

If an EU country decides not to take up all of its pro rata allocation, “the doses are redistributed among the other interested member states,” spokesman Stefan De Keersmaecker said in a written statement.

“It would be up to the member states to find an agreement if they wished to return to the pro rata basis,” De Keersmaecker said.

On Saturday, the Netherlands rejected Austria's allegations that it had procured additional vaccination doses outside the scope of EU agreements.

The country receives vaccines through the designated EU mechanism, but makes use of leeway granted by the bloc, a Health Ministry said.

If a country waives its right to its full allocation, other countries can gain access to it, as the Netherlands had done, the spokesman pointed out.

Around 1.4 million residents of the Netherlands have received at least one vaccine dose so far. More than 400,000 have already received both jabs, which corresponds to about 2.5 per cent of the population.

Malta also rejected similar allegations. Maltese Health Minister Chris Fearne said the country had procured its doses through the EU distribution mechanism.

The EU countries have each opted for different mixes of vaccines, some preferring to buy more of the cheaper and easier-to-store AstraZeneca shot, for example.

But major production difficulties affecting the British-Swedish pharmaceutical firm’s EU supply chain have severely hampered deliveries, putting national governments under pressure.

1